28 related news articles for Amnion Cell Biology

Exciting new treatments for unmet medical needs including ovarian cancer have been awarded significant funding from Australia’s national biotechnology incubator, CUREator.…  Read more

A long-awaited treatment for a common cause of cancer is a big step closer thanks to Federal Government NHMRC funding – offering hope that naturally occurring nanoparticles will be the missing link for treating chronic liver disease.…  Read more

An effective treatment is closer than ever for one of the most devastating conditions affecting premature babies, with researchers at Hudson Institute further refining their world-first method of treating BPD (Bronchopulmonary dysplasia).…  Read more

A promising avenue of research into chronic lung disease treatment has hit a speed bump, with new research showing that 3D manufacturing mesenchymal stem cells (MSCs) may not be the panacea that was hoped.…  Read more

A cell therapy could reduce inflammatory response in liver disease, offering hope to thousands of Australians suffering from the disease.…  Read more

Research into a chronic lung disease in premature babies is leading Hudson Institute researchers to develop new protocols on how to treat infants with cell-based therapies. …  Read more

Crohn’s is an inflammatory disease which affects the gastrointestinal tract. It is incurable and usually chronic with periods of flare ups lasting from anywhere from a few days to a several months.…  Read more

A cutting-edge new treatment for a fatal lung disease is one step closer thanks to a discovery by Hudson Institute stem cell therapy researchers.…  Read more

Ten Hudson Institute PhD students have been selected for the first time to participate in the high-level mentoring program, Industry Mentoring Network in STEM (IMNIS).…  Read more

Associate Professor Rebecca Lim has been awarded $300,000 from the Victorian Medical Research Acceleration Fund to progress her laboratory’s research into a new regenerative medicine,…  Read more

Associate Professor Rebecca Lim has been awarded more than $470,000 from the Australian Government’s Medical Research Future Fund to pursue research into stem cell therapies for liver disease.…  Read more

More than 200,000 people have died from COVID-19 since January 2020. While Australia has been relatively spared from the onslaught of infections and deaths, our nation’s scientists need to be part of the global effort to address this pandemic.…  Read more

Congratulations to Dr Gina Kusuma, who has been awarded a two-year Rebecca L Cooper Medical Research Foundation Project Grant to investigate cell-free therapeutics which can mediate vascular regeneration in the aged population.…  Read more

Hudson Institute and Monash University researchers have assessed the long-term outcomes of their world-first study that used placental stem cells in premature babies with severe bronchopulmonary dysplasia, a form of chronic lung disease.…  Read more

Early career Hudson Institute researcher, Dr Gina Kusuma has been awarded the prestigious Victoria Fellowship 2019. Coordinated by veski, this award is funded by the State Government of Victoria and recognises quality research from promising young scientists.…  Read more

There is a major gap in the rapidly growing cell therapy industry: qualified staff who can undertake the cell manufacturing needed as part of the therapy. …  Read more

A world‐first safety trial is underway examining amniotic stem cells as therapy for acute stroke. The study is a partnership between Hudson Institute of Medical Research, Monash Health and La Trobe University.…  Read more

Associate Professor Rebecca Lim is now formally among the top scientists in Australia after being ranked the highest applicant in the industry category for the 2018 National Health and Medical Research Council (NHMRC) Career Development Fellowship Scheme. The award is given to the highest ranked applicant in the biomedical, clinical, industry and population health pillars…  Read more

A naturally occurring ‘sleep hormone’ could help prevent early delivery in pregnant women with the life-threatening complication, preeclampsia, a new study has found.…  Read more

Lung fibrosis patients could soon inhale ‘droplets’ of tiny particles derived from stem-like cells found in the human placenta in an effort to repair ‘irreversible’ deadly scarring of the lungs, thanks to world-first research. The regenerative medicine treatment could one day form an alternative for patients with the disease who aren’t eligible for a life-saving…  Read more

Hudson Institute has had outstanding success in the recent National Health and Medical Research Council (NHMRC) Fellowship and Development Grant announcements.…  Read more

A world-first therapy, developed at Hudson Institute of Medical Research and Monash University, using cells from the human placenta to repair the damaged lungs of premature babies, is giving hope to families of the most fragile infants like Harry Campbell. The results of a clinical trial at the Monash Children’s Hospital – the culmination of…  Read more

A world-leading Melbourne innovation is rapidly changing the way cell therapies are manufactured to treat diseases including stroke and cerebral palsy, taking these treatments out of the lab and into hospitals. The new cell-processing technology, ROTEA, developed by Melbourne start-up, Scinogy in conjunction with Hudson Institute of Medical Research, is significantly reducing the costs and…  Read more

Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

Leading Australian stem cell researcher, Dr Rebecca Lim has just returned from Toronto, the global centre of cell therapies research and a hotbed of innovation and start-ups. She shares what happens when science meets innovation and commercialisation. You’ve just been to Toronto, Canada to visit the Centre for Commercialisation of Regenerative Medicine. What was the…  Read more

Dr Rebecca Lim has been invited to present her work with Business Development Director, Rob Merriel on amniotic exosomes at the prestigious Stanford University BIO SPARK Showcase in San Francisco on 17 October.…  Read more

Federal Member for Chisholm and former speaker, Anna Burke, and City of Monash Mayor, Cr Stefanie Perri, toured the Monash Health Translation Precinct’s (MHTP) new $84 million Translational Research Facility yesterday (Monday, February 15).…  Read more

Hudson Institute’s Dr Rebecca Lim has been awarded the inaugural Fielding Fellowship to conduct her research into stem cell-like therapy to treat lung damage in premature babies.…  Read more